| Anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00011 events11 affected8,864 at risk
- EG00115 events15 affected8,869 at risk
|
| Anaemia megaloblastic | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anaemia of chronic disease | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Aplastic anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bone marrow failure | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haemolytic anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lymphadenopathy mediastinal | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Normochromic normocytic anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pernicious anaemia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Splenic haemorrhage | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Splenic infarction | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Splenomegaly | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thrombocytopenic purpura | Blood and lymphatic system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| AV dissociation | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00010 events10 affected8,864 at risk
- EG00110 events10 affected8,869 at risk
|
| Angina unstable | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00065 events65 affected8,864 at risk
- EG00156 events56 affected8,869 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0009 events9 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Atrioventricular block first degree | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bradycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG00110 events10 affected8,869 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cardiac asthma | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00019 events19 affected8,864 at risk
- EG00116 events16 affected8,869 at risk
|
| Cardiac valve sclerosis | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Congestive cardiomyopathy | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Coronary artery occlusion | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Extrasystoles | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intracardiac thrombus | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Mitral valve disease | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Myocarditis | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Palpitations | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pericarditis | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Sick sinus syndrome | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Sinus bradycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Supraventricular extrasystoles | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Tachycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Tachycardia paroxysmal | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Ventricular flutter | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Wolff-Parkinson-White syndrome | Cardiac disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Congenital intestinal malformation | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Duchenne muscular dystrophy | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hereditary haemorrhagic telangiectasia | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hydrocele | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lymphangioma | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Phimosis | Congenital, familial and genetic disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Auricular swelling | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Deafness unilateral | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Meniere's disease | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Tympanic membrane perforation | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Vestibular neuronitis | Ear and labyrinth disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Addison's disease | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyperparathyroidism | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Inappropriate antidiuretic hormone secretion | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pituitary cyst | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Thyroid disorder | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Thyroid mass | Endocrine disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Amaurosis fugax | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Blindness | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cataract | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0008 events8 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Diplopia | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ectropion | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Endophthalmitis | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Eyelid ptosis | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lacrimal disorder | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lenticular opacities | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Macular degeneration | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Retinal detachment | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Retinal tear | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Visual acuity reduced | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Visual disturbance | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Vitreous detachment | Eye disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abdominal distension | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Abdominal strangulated hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Abdominal wall disorder | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abdominal wall haematoma | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Appendicitis perforated | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Barrett's oesophagus | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Colitis ulcerative | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Colonic polyp | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Colonic stenosis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0008 events8 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Duodenal ulcer perforation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Enterocele | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Enterovesical fistula | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Erosive oesophagitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Faecaloma | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Food poisoning | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastric perforation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastric polyps | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Gastric ulcer perforation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastritis haemorrhagic | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gastrointestinal disorder | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00013 events13 affected8,864 at risk
- EG00120 events20 affected8,869 at risk
|
| Gastrointestinal inflammation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gastrointestinal pain | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00015 events15 affected8,864 at risk
- EG00117 events17 affected8,869 at risk
|
| Inguinal hernia, obstructive | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Intestinal stenosis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Intra-abdominal haematoma | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Intra-abdominal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Large intestinal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Odynophagia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Oesophageal achalasia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Oesophageal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Oesophageal rupture | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Oesophageal varices haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Oesophagitis haemorrhagic | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Pancreatolithiasis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Peptic ulcer haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Peritonitis | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Proctalgia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rectal polyp | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Rectal prolapse | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Salivary gland calculus | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Salivary gland cyst | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Small intestinal haemorrhage | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Spigelian hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Swollen tongue | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0018 events8 affected8,869 at risk
|
| Umbilical hernia, obstructive | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Volvulus | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Adhesion | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Adverse drug reaction | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Asthenia | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Calcinosis | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Chest discomfort | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Chest pain | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Death | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00034 events34 affected8,864 at risk
- EG00130 events30 affected8,869 at risk
|
| Deformity | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dysplasia | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Fatigue | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| General physical health deterioration | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hernia | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Hernia obstructive | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Malaise | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Mucosal inflammation | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Multi-organ failure | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00022 events22 affected8,864 at risk
- EG00129 events29 affected8,869 at risk
|
| Oedema peripheral | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pyrexia | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Sudden death | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Systemic inflammatory response syndrome | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ulcer | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ulcer haemorrhage | General disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Biliary colic | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Biliary dyskinesia | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cholangitis sclerosing | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0009 events9 affected8,864 at risk
- EG00110 events10 affected8,869 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00023 events23 affected8,864 at risk
- EG00122 events22 affected8,869 at risk
|
| Cirrhosis alcoholic | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gallbladder polyp | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hepatic cyst | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic cyst ruptured | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hepatic function abnormal | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic mass | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hepatic pain | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Hepatitis cholestatic | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hydrocholecystis | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Jaundice cholestatic | Hepatobiliary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Allergy to arthropod sting | Immune system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Sarcoidosis | Immune system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Abdominal sepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Abscess intestinal | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Abscess limb | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Abscess rupture | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Appendicitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Arthritis bacterial | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Arthritis infective | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Aspergillosis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Atypical mycobacterial infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bacteraemia | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bacterial infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bronchiectasis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Bronchitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Bronchitis bacterial | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bronchopneumonia | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Campylobacter gastroenteritis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cellulitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00020 events20 affected8,864 at risk
- EG00113 events13 affected8,869 at risk
|
| Cholecystitis infective | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Clostridial infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Corneal abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cystitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Device related infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Diarrhoea infectious | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Diverticulitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00016 events16 affected8,864 at risk
- EG00113 events13 affected8,869 at risk
|
| Empyema | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Endocarditis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Epiglottitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Erysipelas | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gangrene | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00011 events11 affected8,864 at risk
- EG0018 events8 affected8,869 at risk
|
| Gastroenteritis clostridial | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| HIV infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haematoma infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatitis A | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatitis C | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Herpes zoster | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Incision site cellulitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Infected cyst | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Infected skin ulcer | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Infectious mononucleosis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Influenza | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Labyrinthitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Laryngitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Liver abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Localised infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0009 events9 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Lung abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lung infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lymphangitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Meningitis pneumococcal | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Meningococcal sepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Oral herpes | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Orchitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Otitis media | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Parotid abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pelvic abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Perianal abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pneumococcal sepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Pneumonia | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00057 events57 affected8,864 at risk
- EG00156 events56 affected8,869 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Pneumonia chlamydial | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pneumonia viral | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Prostate infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pseudomonas infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pulmonary tuberculosis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Rash pustular | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Rectal abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Scrotal infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Sepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Septic shock | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Sialoadenitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Sinusitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Staphylococcal bacteraemia | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Subacute endocarditis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Tooth abscess | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Tracheitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG00115 events15 affected8,869 at risk
|
| Urosepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Viral infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Viral pericarditis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Vulvitis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Wound infection | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Wound sepsis | Infections and infestations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Animal bite | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0009 events9 affected8,864 at risk
- EG00114 events14 affected8,869 at risk
|
| Back injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bone fissure | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Brain contusion | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cartilage injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Caustic injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Crush injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Device dislocation | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Dislocation of joint prosthesis | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Drug toxicity | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Eye injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0018 events8 affected8,869 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Forearm fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Foreign body in eye | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gun shot wound | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00014 events14 affected8,864 at risk
- EG00115 events15 affected8,869 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ligament injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lung injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Medical device complication | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Meniscus lesion | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Multiple injuries | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Muscle injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Neck injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nerve injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Periorbital haematoma | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Post-traumatic pain | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pubic rami fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Retinal injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0008 events8 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Scrotal haematoma | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Skin laceration | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Splenic rupture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Synovial rupture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thoracic vertebral fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Traumatic brain injury | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Urinary retention postoperative | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anticonvulsant drug level increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Blood creatinine increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Blood pressure increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Electrocardiogram T wave inversion | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gamma-glutamyltransferase increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Heart rate increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Heart rate irregular | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| International normalised ratio increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Oxygen saturation decreased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Prostatic specific antigen increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Weight decreased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| White blood cell count increased | Investigations | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0008 events8 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00013 events13 affected8,864 at risk
- EG00114 events14 affected8,869 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypermagnesaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypernatraemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyperphosphataemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypoalbuminaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypocalcaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Lipomatosis | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Obesity | Metabolism and nutrition disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ankylosing spondylitis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00053 events53 affected8,864 at risk
- EG00148 events48 affected8,869 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0018 events8 affected8,869 at risk
|
| Bone pain | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Bunion | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00012 events12 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Joint contracture | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Joint crepitation | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Joint effusion | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Muscle atrophy | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Muscle disorder | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Muscle haemorrhage | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Muscle swelling | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00015 events15 affected8,864 at risk
- EG00117 events17 affected8,869 at risk
|
| Osteolysis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Polymyositis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pseudarthrosis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Spondylolisthesis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Acute myelomonocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Adenoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Adrenal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Astrocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Astrocytoma malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Benign breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Benign neoplasm of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Benign renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Benign salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bile duct cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0008 events8 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Bladder papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Brain cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00022 events22 affected8,864 at risk
- EG00120 events20 affected8,869 at risk
|
| Breast cancer in situ | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Bronchial neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Carcinoid tumour of the small bowel | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Carcinoid tumour of the stomach | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Carcinoma in situ of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cervix carcinoma stage III | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cervix neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cholesteatoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00020 events20 affected8,864 at risk
- EG00116 events16 affected8,869 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Colon cancer stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Colon cancer stage III | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Colon neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Ganglioneuroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Gastrointestinal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Gastrointestinal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Gastrointestinal stromal tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Gastrooesophageal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Glioblastoma multiforme | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Glioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Head and neck cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hepatic neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Large cell carcinoma of the respiratory tract stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Leiomyosarcoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lip and/or oral cavity cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Liposarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Lung adenocarcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00013 events13 affected8,864 at risk
- EG00110 events10 affected8,869 at risk
|
| Lung squamous cell carcinoma stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Lymphoplasmacytoid lymphoma/immunocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Mantle cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Mesothelioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Metastatic malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Metastatic squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Multiple myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Mycosis fungoides | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Myelofibrosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Nasopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Neoplasm prostate | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Neuroendocrine carcinoma of the skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Neurofibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ocular neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Oesophageal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Oesophageal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Oesophageal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ovarian adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Ovarian cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ovarian fibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ovarian neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Papillary thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Penis carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Phaeochromocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pharyngeal cancer stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pituitary tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Plasmacytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Polycythaemia vera | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00038 events38 affected8,864 at risk
- EG00134 events34 affected8,869 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Prostatic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pseudomyxoma peritonei | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Rectosigmoid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Renal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal oncocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Rhabdomyosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Salivary gland cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Signet-ring cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Skin neoplasm bleeding | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Small cell lung cancer stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Squamous cell carcinoma of the cervix | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| T-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Testis cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Throat cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thyroid adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thyroid neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Tongue neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Tonsil cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Ureteric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Ureteric cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Waldenstrom's macroglobulinaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Anoxic encephalopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anticholinergic syndrome | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cerebellar atrophy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cerebral ischaemia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Cerebrovascular disorder | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cervical myelopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cervicobrachial syndrome | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Convulsion | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Demyelinating polyneuropathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Dizziness | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Drop attacks | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Drug withdrawal convulsions | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dysaesthesia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Encephalitis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Encephalopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Epilepsy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Facial neuralgia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Facial palsy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Grand mal convulsion | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Headache | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Hemicephalalgia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hydrocephalus | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hypertonia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypoglycaemic coma | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Intracranial pressure increased | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Migraine | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Myasthenia gravis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Myxoedema coma | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nerve compression | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nerve root compression | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Optic neuritis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Paralysis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Paraplegia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Peripheral paralysis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pneumocephalus | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Presyncope | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0015 events5 affected8,869 at risk
|
| Radiculitis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Radiculopathy | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ruptured cerebral aneurysm | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Sciatica | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Senile dementia | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Sensory loss | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Spinal cord compression | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Syncope | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00015 events15 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00010 events10 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Tremor | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Vocal cord paralysis | Nervous system disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Aggression | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Alcohol abuse | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Alcoholism | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Anxiety | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Confusional state | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Delirium | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Depression | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Insomnia | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Major depression | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Panic attack | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Psychotic disorder | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Suicidal ideation | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Azotaemia | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bladder diverticulum | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bladder obstruction | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bladder prolapse | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Bladder stenosis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cystitis interstitial | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Glomerulonephritis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00012 events12 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Pollakiuria | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Renal failure acute | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Renal failure chronic | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal haemorrhage | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal mass | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Renal pain | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Renal tubular necrosis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Urethral obstruction | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Urethral polyp | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Urinary bladder haemorrhage | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Urinary tract obstruction | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Vesical fistula | Renal and urinary disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00017 events17 affected8,864 at risk
- EG00112 events12 affected8,869 at risk
|
| Cervical polyp | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Cystocele | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Endometrial hypertrophy | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Epididymitis | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Erectile dysfunction | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Female genital tract fistula | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Genital cyst | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Ovarian mass | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pelvic pain | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Prostatic disorder | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Prostatism | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Rectocele | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Testicular swelling | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Uterine cervical erosion | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Uterine polyp | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Uterovaginal prolapse | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Vaginal fistula | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Vaginal prolapse | Reproductive system and breast disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Alveolitis allergic | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0016 events6 affected8,869 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00033 events33 affected8,864 at risk
- EG00125 events25 affected8,869 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dysphonia | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0006 events6 affected8,864 at risk
- EG0018 events8 affected8,869 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Eosinophilic pneumonia chronic | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Foreign body aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hydrothorax | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypoventilation | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Laryngeal leukoplakia | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pharyngolaryngeal pain | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00014 events14 affected8,864 at risk
- EG00111 events11 affected8,869 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0004 events4 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Respiratory disorder | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00012 events12 affected8,864 at risk
- EG00112 events12 affected8,869 at risk
|
| Sinus disorder | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Dermatitis exfoliative | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Facial hemiatrophy | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Rash erythematous | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Skin disorder | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Skin nodule | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Stevens-Johnson syndrome | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Telangiectasia | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Cholecystectomy | Surgical and medical procedures | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Hip arthroplasty | Surgical and medical procedures | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Pancreatectomy | Surgical and medical procedures | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0005 events5 affected8,864 at risk
- EG0013 events3 affected8,869 at risk
|
| Aortic aneurysm rupture | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Aortic dissection | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0014 events4 affected8,869 at risk
|
| Arterial occlusive disease | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Arterial thrombosis limb | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG00013 events13 affected8,864 at risk
- EG0017 events7 affected8,869 at risk
|
| Embolism | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Haematoma | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0003 events3 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Hypertension | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0007 events7 affected8,864 at risk
- EG0019 events9 affected8,869 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Hypertensive emergency | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hypotension | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Lymphoedema | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Phlebitis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0011 events1 affected8,869 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Thrombosis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|
| Varicose vein | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0002 events2 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Vascular pseudoaneurysm | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0000 events0 affected8,864 at risk
- EG0012 events2 affected8,869 at risk
|
| Venous thrombosis | Vascular disorders | MedDRA MedDRA14.0 | Systematic Assessment | | - EG0001 events1 affected8,864 at risk
- EG0010 events0 affected8,869 at risk
|